Jean Chalaoui
Papers
1
Total Citations
33
H-Index
1
About
Dr. Jean Chalaoui is a leading figure in radiation oncology, with a focused expertise in stereotactic body radiotherapy (SBRT) for lung cancer. His most cited work, a 2014 study on patient-adapted robotic lung SBRT using the CyberKnife system, demonstrated excellent cancer outcomes for early-stage non-small cell lung cancer in a cohort of 150 patients. This research has garnered 33 citations, underscoring its influence in refining treatment protocols. A critical contribution of Dr. Chalaoui’s work is his nuanced finding that while SBRT is highly effective, it warrants caution in patients with idiopathic pulmonary fibrosis, a key safety insight that has shaped clinical decision-making. His emphasis on patient-adapted approaches highlights a commitment to personalized oncology, balancing efficacy with risk. Dr. Chalaoui’s research continues to inform best practices in lung cancer radiotherapy, making him a respected voice in the field for both students and clinicians seeking to optimize outcomes while managing complex patient comorbidities.
Research Focus
Key Achievements
Top Papers
- 1